This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Scripps Korea Antibody Institute, Abtlas Co., Ltd.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2025
Title: **The Innovative Patents of Jong Rip Choi**
Introduction
Jong Rip Choi, an inventive force hailing from Gangwon-do, South Korea, holds a significant place in the world of biotechnology with three patents to his name. His work primarily focuses on the development of antibodies and protein libraries aimed at advancing cancer treatment.
Latest Patents
Among his latest patents is the innovative "Antibodies against programmed death-ligand 1 and uses thereof." This patent discloses an antibody targeting programmed death-ligand 1 (PD-L1) or its antigen-binding fragment, along with the relevant nucleic acid, vector, and transfected cells. This invention plays a crucial role in establishing compositions for preventing or treating cancer, and it also encompasses a combination therapy for more effective cancer treatment.
Another notable patent is the "Protein combination-based Fv library, and preparation method therefor." This invention outlines a method for constructing an Fv library that utilizes a combination of proteins. This approach allows researchers to screen desired antibodies efficiently without the need for target antigen preparations, significantly streamlining the process of antibody discovery. The reduction in protein purification processes also decreases costs and time compared to conventional DNA-based libraries.
Career Highlights
Jong Rip Choi has made invaluable contributions to the field of biotechnology, particularly during his tenure at the Scripps Korea Antibody Institute and Abtlas Co., Ltd. Through his work, he has not only contributed to scientific advancements but has also gained recognition for his innovative approaches to antibody development.
Collaborations
Throughout his career, Jong has collaborated with notable colleagues such as Suk Mook Lee and Min Kyoung Ki. These partnerships reflect a commitment to research excellence and innovation, as they work together to push the boundaries of what is possible in the life sciences.
Conclusion
Jong Rip Choi's innovative patents and collaborative spirit make him a significant figure in biotechnology and cancer research. His contributions through his latest patents highlight the potential for advancements in treating cancer, demonstrating the importance of innovation and invention in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile